Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2012 1
2013 2
2014 3
2015 3
2016 2
2017 3
2018 1
2019 3
2020 3
2021 7
2022 4
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

PubMed for id: 1650313

35 results

Results by year

Filters applied: . Clear all
Page 1
Primary Management of Operable Locally Advanced Oral Cavity Squamous Cell Carcinoma: Current Concepts and Strategies.
Asarkar AA, Chang BA, de Bree R, Kowalski LP, Guntinas-Lichius O, Bradley PJ, de Graaf P, Strojan P, Rao KN, Mäkitie AA, López F, Rinaldo A, Palme C, Genden EM, Sanabria A, Rodrigo JP, Ferlito A. Asarkar AA, et al. Adv Ther. 2024 Jun;41(6):2133-2150. doi: 10.1007/s12325-024-02861-6. Epub 2024 Apr 20. Adv Ther. 2024. PMID: 38642199 Review.
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures.
Corti A, De Cecco L, Cavalieri S, Lenoci D, Pistore F, Calareso G, Mattavelli D, de Graaf P, Leemans CR, Brakenhoff RH, Ravanelli M, Poli T, Licitra L, Corino V, Mainardi L. Corti A, et al. Biomark Res. 2023 Jul 16;11(1):69. doi: 10.1186/s40364-023-00494-5. Biomark Res. 2023. PMID: 37455307 Free PMC article.
Poor tumor differentiation is an independent adverse prognostic variable in patients with locally advanced oral cavity cancer--Comparison with pathological risk factors according to the NCCN guidelines.
Lee LY, Lin CY, Cheng NM, Tsai CY, Hsueh C, Fan KH, Wang HM, Hsieh CH, Ng SH, Yeh CH, Lin CH, Tsao CK, Fang TJ, Huang SF, Lee LA, Kang CJ, Fang KH, Wang YC, Lin WN, Hsin LJ, Yen TC, Liao CT. Lee LY, et al. Cancer Med. 2021 Oct;10(19):6627-6641. doi: 10.1002/cam4.4195. Epub 2021 Sep 17. Cancer Med. 2021. PMID: 34533269 Free PMC article.
35 results